What Conditions Can Mimic Myelodysplastic Syndrome?
At a Glance
Abnormal blood counts and bone marrow cells do not prove myelodysplastic syndrome. Copper deficiency, medicines, infections, autoimmune disease, organ problems, and other marrow disorders can look similar, so doctors combine your history with targeted blood, marrow, and genetic tests.
Because symptoms like fatigue and low blood counts are common in myelodysplastic syndrome (MDS), it is easy to assume that abnormal-looking bone marrow cells automatically confirm the diagnosis. However, dysplasia (abnormal-looking cells) and cytopenias (low blood cell counts) are not unique to MDS. Many other conditions—including nutritional deficiencies, medication side effects, infections, autoimmune diseases, and other bone marrow disorders—can suppress your bone marrow and cause your cells to look abnormal.
These “mimics” are potentially treatable or reversible contributors, and clinicians must carefully evaluate them before diagnosing a true myeloid neoplasm (blood cancer) like MDS [1]. It is also possible for these conditions to coexist with MDS, explaining only part of your abnormal counts.
Safety Warning: If you experience a fever while your white blood cell count is low (neutropenia), uncontrolled bleeding, severe shortness of breath, or rapidly worsening weakness, seek immediate medical attention. Never stop a prescribed medication or delay MDS care without speaking to your care team.
Nutritional Deficiencies
Nutritional imbalances can cause bone marrow changes that resemble MDS, but diagnosing and correcting them should always be guided by a clinician.
- Vitamin B12 and Folate: Severe deficiencies in these vitamins can cause low blood counts and marrow changes that closely resemble MDS [2]. If your B12 levels are borderline, your doctor might check your methylmalonic acid (MMA) and homocysteine levels. However, these tests require careful interpretation, as kidney dysfunction can also elevate MMA [2].
- Copper Deficiency and Zinc Excess: This is an important, frequently overlooked mimic [3]. Low copper can cause anemia, low white blood cell counts, and ring sideroblasts (developing red blood cells with an abnormal ring of iron around the nucleus) [3]. Copper deficiency is often linked to prior gastric surgery, malabsorption, or excess zinc [4]. Taking excess zinc—from dietary supplements or zinc-based denture adhesives—blocks copper absorption [3].
- Iron and Thyroid Issues: Severe iron deficiency, iron overload, and hypothyroidism can also contribute to abnormal blood counts and must be evaluated.
Medications, Toxins, and Liver/Kidney Disease
Everything you ingest—and how your organs process it—affects your blood.
- Medications: Certain medications, such as immunosuppressants, antibiotics, or previous chemotherapy, can suppress your bone marrow [5]. Never abruptly stop a prescription medicine on your own. Your doctor will review your medication list and may safely pause or substitute a suspected drug while monitoring your blood counts over time [5].
- Liver Disease and Alcohol: Heavy alcohol consumption and liver cirrhosis can cause low blood counts without primary bone marrow disease [6]. For instance, cirrhosis can lead to an enlarged spleen that traps platelets, lowering your counts [6].
- Kidney Disease: Chronic kidney disease is a common cause of anemia because damaged kidneys produce less erythropoietin (a hormone that stimulates red blood cell production) [7]. This typically causes isolated anemia rather than the broad dysplasia seen in MDS.
Infections
When your body fights off an infection, your bone marrow can become “reactive,” temporarily altering blood cell production [8].
- Viral Infections: Viruses such as HIV, Hepatitis B or C, Epstein-Barr virus (EBV), and cytomegalovirus (CMV) can suppress the bone marrow [8]. Parvovirus B19 specifically targets red blood cell production, severely lowering your red cell count. Even COVID-19 can occasionally cause temporary cytopenias [9]. Your hematologist will order specific viral tests based on your clinical picture and exposure history rather than running a universal panel.
Autoimmune and Inflammatory Disorders
Conditions where your immune system attacks your own body can also affect your bone marrow:
- Autoimmune Diseases: Disorders like lupus (SLE) or rheumatoid arthritis can cause your immune system to destroy healthy blood cells or suppress their production [10].
- VEXAS Syndrome: This is a rare inflammatory disorder caused by an acquired (somatic) mutation in the UBA1 gene [11]. It usually affects older men (though not exclusively) and causes unexplained fevers, systemic symptoms (like severe joint pain or skin rashes), and vacuoles (bubble-like spaces) in marrow cells [11]. Because vacuoles can occur in other conditions, diagnosis requires matching the clinical inflammatory pattern with the specific UBA1 mutation [11].
Aplastic Anemia and Other Marrow Disorders
Sometimes the challenge lies in distinguishing MDS from other rare bone marrow failure diseases.
- Aplastic Anemia vs. Hypoplastic MDS: Typical MDS often features a hypercellular (more crowded than expected for your age) bone marrow [12]. In contrast, aplastic anemia generally features a hypocellular (less cellular or “emptier”) marrow [12]. However, a rare subtype called hypoplastic MDS also has a hypocellular marrow [13]. Distinguishing them is complex and requires experts to integrate your age-adjusted cellularity, blast percentage, genetics, and clinical history [13].
- Paroxysmal Nocturnal Hemoglobinuria (PNH): This rare, acquired blood disorder can cause red blood cell destruction and blood clots, and it sometimes overlaps with aplastic anemia or MDS [14].
How Doctors Tell the Difference
Because low counts and dysplasia are not specific to MDS, a diagnosis requires integrating multiple tests over time [15]:
- Detailed History and Blood Tests: Your doctor will evaluate your diet, prior surgeries, medications, and specific lab tests (like kidney/liver function, vitamins, iron studies, and viral markers).
- Advanced Bone Marrow Testing: Doctors rely on cytogenetics (testing the chromosomes inside the cells) and flow cytometry (a laser-based test to analyze cell features) to look for abnormalities [16] [17]. While finding a specific abnormality can strongly support an MDS diagnosis, a normal result does not completely rule out MDS [16].
- Molecular Profiling (DNA Sequencing): Finding a genetic mutation in your blood cells does not automatically confirm MDS. Some older adults develop mutations without diagnostic cytopenias—a condition called Clonal Hematopoiesis of Indeterminate Potential (CHIP) [18]. While CHIP is not MDS, it is not harmless, as it increases the future risk of blood cancers and cardiovascular disease [18]. If you have low blood counts and a mutation but do not meet the full criteria for MDS, doctors may call this Clonal Cytopenia of Undetermined Significance (CCUS) [18]. Ultimately, no single genetic or visual finding provides a simple “yes or no” answer; diagnosis requires careful review by an experienced hematopathologist [16].
Common questions in this guide
What conditions can look like myelodysplastic syndrome besides B12 or folate deficiency?
How can copper deficiency be confused with MDS?
Can medications or organ disease cause blood counts that resemble MDS?
What tests help doctors tell MDS from another cause of low blood counts?
Does finding a mutation in my blood mean that I have MDS?
When should I seek emergency care if my blood counts are low?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my symptoms and lab work, which reversible causes of low blood counts have we already evaluated, and which ones are we still investigating?
- 2.Which additional tests (like MMA, homocysteine, copper, or specific viral markers) are appropriate for my history, and how might my kidney function or supplements affect their interpretation?
- 3.Could any of my current prescription medications, over-the-counter drugs, or dietary supplements be contributing to my low blood counts, and how can we safely manage them?
- 4.Does my bone marrow biopsy report mention features that overlap with aplastic anemia, an autoimmune condition, or a specific genetic mutation?
- 5.If you found a genetic mutation in my blood, does it fit the strict criteria for MDS, or could it be CHIP (Clonal Hematopoiesis of Indeterminate Potential) or CCUS?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (18)
- 1
Pernicious anemia: a myelodysplastic syndrome look-alike.
Kesbeh Y, Pakbaz Z
Journal of community hospital internal medicine perspectives 2019; (9(3)):240-243 doi:10.1080/20009666.2019.1622382.
PMID: 31258865 - 2
Unmasking Vitamin B12 Deficiency Misdiagnosed as Myelodysplastic Syndrome.
Jamil M, Nasser Z, Jamil D, Sheqwara JZ
Case reports in hematology 2024; (2024()):3258227 doi:10.1155/2024/3258227.
PMID: 39655186 - 3
Zinc-Induced Hematologic Toxicities: A Systematic Review of Descriptive Studies.
Dutta A, Chaudhary V, Kumari S, et al.
Biological trace element research 2026; (204(9)):6628-6642 doi:10.1007/s12011-026-05136-z.
PMID: 42087025 - 4
Diagnostic pitfalls of ESA-resistant anemia due to functional copper deficiency in a dialysis patient: a myelodysplastic syndrome mimic.
Ikegishi Y, Abe R, Maehata A, Takiyama Y
CEN case reports 2026; (15(1)):37 doi:10.1007/s13730-025-01042-w.
PMID: 41591643 - 5
Spectrum of Myelodysplastic Syndrome in Patients Evaluated for Cytopenia(s). A Report from a Reference Centre in Saudi Arabia.
AlMozain N, Mashi A, Alneami Q, et al.
Hematology/oncology and stem cell therapy 2022; (15(2)):39-44 doi:10.1016/j.hemonc.2020.11.001.
PMID: 33227261 - 6
Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia.
Koschade SE, Moser LM, Sokolovskiy A, et al.
Journal of clinical medicine 2023; (12(13)) doi:10.3390/jcm12134373.
PMID: 37445409 - 7
Anemia at older age: etiologies, clinical implications, and management.
Stauder R, Valent P, Theurl I
Blood 2018; (131(5)):505-514 doi:10.1182/blood-2017-07-746446.
PMID: 29141943 - 8
[Differential diagnosis of reactive cytopenias].
Menter T, Dirnhofer S, Tzankov A
Pathologie (Heidelberg, Germany) 2022; (43(4)):263-270 doi:10.1007/s00292-022-01076-2.
PMID: 35925221 - 9
Thiamine-Responsive Megaloblastic Anemia Syndrome Mimicking Myelodysplastic Neoplasm.
Klötzer C, Schnabel F, Kubasch AS, et al.
Acta haematologica 2025; (148(4)):380-385 doi:10.1159/000542286.
PMID: 39467528 - 10
Long-term immunosuppression and multiple transplants predispose systemic lupus erythematosus patients with cytopenias to hematologic malignancies.
Lanjewar S, McFarlane IM, Parker KN, et al.
Medicine 2021; (100(21)):e25985 doi:10.1097/MD.0000000000025985.
PMID: 34032713 - 11
Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
Patel N, Dulau-Florea A, Calvo KR
Seminars in hematology 2021; (58(4)):204-211 doi:10.1053/j.seminhematol.2021.10.007.
PMID: 34802541 - 12
Early and Long-Lasting Hematologic Recovery in a Young Adult With Severe Aplastic Anemia Treated With Romiplostim, Horse-Anti-Thymocyte Globulin (ATG), and Cyclosporine A: A Case Report.
Kakizaki E, Higashi T, Akao K, et al.
Cureus 2025; (17(10)):e94634 doi:10.7759/cureus.94634.
PMID: 41113867 - 13
Hypoplastic Myelodysplastic Syndromes: Just an Overlap Syndrome?
Fattizzo B, Serpenti F, Barcellini W, Caprioli C
Cancers 2021; (13(1)) doi:10.3390/cancers13010132.
PMID: 33401595 - 14
A flow cytometric approach to compare stem cell apoptosis in aplastic anemia and hypoplastic myelodysplastic syndrome.
Ibrahim M, Khodeary A, Aziz SP, et al.
Hematology/oncology and stem cell therapy 2024; (17(3)):184-189 doi:10.4103/hemoncstem.HEMONCSTEM-D-24-00008.
PMID: 39412754 - 15
How I Diagnose Low-Grade Myelodysplastic Syndromes.
Siddon AJ, Hasserjian RP
American journal of clinical pathology 2020; (154(1)):5-14 doi:10.1093/ajcp/aqaa046.
PMID: 32458977 - 16
Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias.
Cremers EMP, Westers TM, Alhan C, et al.
European journal of cancer (Oxford, England : 1990) 2016; (54()):49-56 doi:10.1016/j.ejca.2015.11.013.
PMID: 26720403 - 17
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Porwit A, Béné MC, Duetz C, et al.
Cytometry. Part B, Clinical cytometry 2023; (104(1)):27-50 doi:10.1002/cyto.b.22108.
PMID: 36537621 - 18
How I use molecular genetic tests to evaluate patients who have or may have myelodysplastic syndromes.
Steensma DP
Blood 2018; (132(16)):1657-1663 doi:10.1182/blood-2018-06-860882.
PMID: 30185432
This page is for informational purposes only and does not constitute medical advice or a diagnosis. A hematologist should evaluate your blood counts and guide any medication, supplement, or follow-up decisions.
Get notified when new evidence is published on Myelodysplastic syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.